Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identify the Optimal TMS Target to Modulate Midcingulate Reward Activity in Smokers

NCT05766254 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT05766254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05766254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identify the Optimal TMS Target to Modulate Midcingulate Reward Activity in Smokers
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Recruiting
Start date
March 24, 2023
Completion date
September 30, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine use disorder